Current status of antifibrinolytic drugs
- 31 March 1989
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 3 (1) , 1-4
- https://doi.org/10.1016/0268-960x(89)90019-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhageNeurology, 1987
- Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding.BMJ, 1987
- Antifibrinolytic Treatment in Subarachnoid HemorrhageNew England Journal of Medicine, 1984
- Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1984
- Myopathy induced by epsilon-aminocaproic acidJournal of Neurosurgery, 1982
- Tranexamic acid: Preoperative prophylactic therapy for patients with hereditary angioneurotic edemaJournal of Allergy and Clinical Immunology, 1977
- Epsilon-Aminocaproic acid therapy in ulcerative colitisDigestive Diseases and Sciences, 1973
- Epsilon Aminocaproic Acid Therapy of Hereditary Angioneurotic EdemaNew England Journal of Medicine, 1972
- The Effect of Tranexamic Acid (Amca) On Postoperative Bleeding After ConizationActa Obstetricia et Gynecologica Scandinavica, 1972
- A SUPPRESSING EFFECT OF ε-AMINO-N-CAPROIC ACID ON THE BLEEDING OF DOGS, PRODUCED WITH THE ACTIVATION OF PLASMIN IN THE CIRCULATORY BLOODThe Keio Journal of Medicine, 1959